| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Servaas Morré | Q73100523 |
| P2093 | author name string | W K Lagrand | |
| H W Niessen | |||
| A J van den Brule | |||
| W Stooker | |||
| P2860 | cites work | Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis | Q69349578 |
| The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells | Q69364130 | ||
| Evidence of type 2 herpes simplex infection in human coronary arteries at the time of coronary artery bypass surgery | Q70839924 | ||
| Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease | Q71730394 | ||
| Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis? | Q72065625 | ||
| [Coronary disease in patients after heart transplantation] | Q72344747 | ||
| [Viral theory of atherosclerosis. Role of cytomegalovirus] | Q72543945 | ||
| Dental infections and coronary atherosclerosis | Q72733298 | ||
| Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study | Q72774085 | ||
| The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo | Q73155086 | ||
| Infection-associated intimal thickening in the coronary arteries of children | Q74464726 | ||
| High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis | Q74471681 | ||
| Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk | Q74501639 | ||
| Absence of PhIP adducts, p53 and Apc mutations, in rats fed a cooked beef diet containing a high level of heterocyclic amines | Q74665125 | ||
| Effects of viral activation of the vessel wall on inflammation and thrombosis | Q74774315 | ||
| Hypothesis: cis-unsaturated fatty acids as potential anti-peptic ulcer drugs | Q74836690 | ||
| C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries | Q77318966 | ||
| Association of Helicobacter pylori infection with elevated serum lipids | Q77910810 | ||
| Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression | Q33791628 | ||
| The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 | ||
| Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies | Q33974569 | ||
| Humoral immune response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplasty | Q33997521 | ||
| Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) | Q34086738 | ||
| Herpes virus infection of endothelium: new insights into atherosclerosis | Q35234479 | ||
| Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. | Q35559048 | ||
| Herpes simplex virus infection in human arterial cells. Implications in arteriosclerosis | Q35581408 | ||
| Cardiovascular lipid accumulation with Coxsackie B virus infection in mice | Q35811360 | ||
| High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis | Q35811381 | ||
| The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients | Q35816869 | ||
| Herpesviridae in the coronary arteries and aorta of young trauma victims | Q35818356 | ||
| Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma | Q36317666 | ||
| In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae | Q36524413 | ||
| C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study | Q36598316 | ||
| Chlamydia pneumoniae in atheroma: consideration of criteria for causality | Q37228857 | ||
| Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study | Q37878753 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
| Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis | Q37878782 | ||
| Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction | Q37878896 | ||
| Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease | Q37878909 | ||
| Chlamydia infections and heart disease linked through antigenic mimicry | Q37878963 | ||
| Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts | Q37879001 | ||
| Antibiotics and risk of subsequent first-time acute myocardial infarction | Q37879181 | ||
| Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension | Q37879204 | ||
| Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients | Q37879407 | ||
| The infection theory in atherosclerosis | Q37879689 | ||
| Bacterial infections and atherosclerosis. | Q37879864 | ||
| Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? | Q37879915 | ||
| A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide | Q37879971 | ||
| Chlamydia pneumoniae and vascular disease | Q37880177 | ||
| Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery. | Q37880226 | ||
| Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis | Q37880332 | ||
| Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 | ||
| High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. | Q37880679 | ||
| Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 | ||
| Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study. | Q51030319 | ||
| New insights into plaque stabilisation by lipid lowering. | Q52531869 | ||
| Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. | Q52867890 | ||
| Developmentally regulated herpesvirus plaque formation in arterial smooth muscle cells. | Q54236159 | ||
| High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis | Q63983805 | ||
| Enterovirus infections as a possible risk factor for myocardial infarction | Q64381784 | ||
| [Cytomegalovirus infection and coronary sclerosis after heart transplantation] | Q68474417 | ||
| Cytomegalovirus and herpes simplex virus in pathogenesis and progression of native arteriosclerosis and recurrent stenosis after intervention | Q37880714 | ||
| Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection | Q37880719 | ||
| Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. | Q37880753 | ||
| Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). | Q37881207 | ||
| Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery | Q37881215 | ||
| Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells | Q37881299 | ||
| Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. | Q37881308 | ||
| Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease | Q37881317 | ||
| Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke | Q37881326 | ||
| The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production | Q37881386 | ||
| Induction of macrophage foam cell formation by Chlamydia pneumoniae | Q37881436 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis | Q37881850 | ||
| Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
| Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis | Q37882356 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| Lymphocyte responses to Chlamydia antigens in patients with coronary heart disease | Q37882557 | ||
| Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction | Q37882562 | ||
| Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen | Q37882581 | ||
| Murine models of Chlamydia pneumoniae infection and atherosclerosis | Q37883205 | ||
| Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms | Q37883353 | ||
| High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement | Q37883688 | ||
| Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group | Q37883953 | ||
| Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease | Q37884972 | ||
| Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery | Q37886058 | ||
| Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators | Q37890128 | ||
| Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain | Q37890285 | ||
| Coxsackie virus infection in acute myocardial infarction | Q39433110 | ||
| Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. | Q39808657 | ||
| Cytomegalovirus and atherosclerosis | Q40726892 | ||
| Herpes simplex virus and atherosclerosis | Q40726900 | ||
| Dental infections as a risk factor for acute myocardial infarction | Q40726911 | ||
| Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease | Q40868032 | ||
| Epidemiology of periodontal diseases. | Q40983659 | ||
| Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice | Q41031324 | ||
| Monocytes harboring cytomegalovirus: interactions with endothelial cells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus delivered by monocytes to sites of vascular injury | Q41103025 | ||
| Cytomegalovirus infection and atherosclerosis | Q41654637 | ||
| Possible role of cytomegalovirus infection in the pathogenesis of human vascular diseases | Q44047909 | ||
| Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis | Q45108781 | ||
| Cytomegalovirus antigen within human arterial smooth muscle cells | Q45224814 | ||
| Incidence and pathophysiologic significance of infected carotid artery plaque | Q45286967 | ||
| Herpes simplex virus type I does not require productive infection to induce tissue factor in human umbilical vein endothelial cells. | Q45775127 | ||
| Coronary artery lesions and human immunodeficiency virus infection | Q45776106 | ||
| Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study | Q45806696 | ||
| Granulocyte-mediated injury to herpes simplex virus-infected human endothelium | Q45846392 | ||
| Influence of the measles virus on the proliferation and protein synthesis of aortic endothelial and smooth muscle cells | Q45849732 | ||
| Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis | Q45851808 | ||
| The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells | Q45862853 | ||
| Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells | Q47756263 | ||
| Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization | Q48409967 | ||
| Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. | Q50866437 | ||
| Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. | Q50892428 | ||
| Patients with diabetes mellitus and atherosclerosis; a role for cytomegalovirus? | Q50951109 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 647-654 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | Microorganisms in the aetiology of atherosclerosis | |
| P478 | volume | 53 |
| Q74438634 | Asymptomatic Internal Carotid Artery Origin Stenosis |
| Q35586029 | Chlamydia pneumoniae in infrequently examined blood vessels |
| Q37862830 | Chlamydia pneumoniae infection: an additional factor for chronic allograft rejection |
| Q90126817 | Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes |
| Q60047506 | Commentary: Comparison of the Protective Effects of Individual Components of Particulated -Sialidase (PTCTS), PTC and TS, against High Cholesterol Diet-Induced Atherosclerosis in Rabbits |
| Q43044342 | Cryptococcus neoformans causes lipid peroxidation; therefore it is a potential inducer of atherogenesis |
| Q37316197 | Emerging role of Toll-like receptors in atherosclerosis |
| Q34562507 | Evidence for the role of Epstein Barr Virus infections in the pathogenesis of acute coronary events |
| Q33262244 | Human immunodeficiency virus impairs reverse cholesterol transport from macrophages |
| Q37857441 | Increased infiltration of Chlamydophila pneumoniae in the vessel wall of human veins after perfusion. |
| Q42083478 | Intracellular infections enhance interleukin-6 and plasminogen activator inhibitor 1 production by cocultivated human adipocytes and THP-1 monocytes |
| Q30377539 | Long-term trends in cardiovascular disease mortality and association with respiratory disease. |
| Q36232292 | No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation |
| Q39887953 | Number of teeth as a predictor of cardiovascular mortality in a cohort of 7,674 subjects followed for 12 years |
| Q92223545 | Oral Bacterial Signatures in Cerebral Thrombi of Patients With Acute Ischemic Stroke Treated With Thrombectomy |
| Q37870946 | Procoagulant and inflammatory response of virus-infected monocytes. |
| Q37702772 | Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. |
| Q78311023 | The other side of the coin: impact of toxin generation and nutrition on the uremic syndrome |
| Q54252809 | Updating the epidemiological transition model. |
Search more.